Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Pain Management Global Trends |
Nov 2009 | £1,895 | 87% |
| The Global Market for Pain Management Drugs and Devices | Aug 2009 | £3,065 | 85% |
| Peripheral Neuropathy and Neuropathic Pain, 2008 Current, Pipeline And Emerging Drugs For The Treatment Of Peripheral Neuropathy And Neuropathic Pain |
Jan 2008 | £1,499 | 84% |
| The Global Pain Therapeutics Market 4th Edition: Market Trends & R&D Insights |
Nov 2010 | £1,105 | 82% |
| Analgesics A Worldwide Market Intelligence Report |
Nov 2009 | £1,895 | 81% |
| Neuropathic Pain - Pipeline Assessment and Market Forecasts to 2016 | Jul 2010 | £1,265 | 80% |
| Acute Pain - Pipeline Review H2 2011 |
Sep 2011 | £315 | 80% |
| CNS Therapeutics A World Market Review |
Nov 2009 | £1,895 | 79% |
| Cancer Supportive Care Products Market to 2016 Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars |
Apr 2011 | £2,215 | 79% |
| Pain Therapeutics, Inc. – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 79% |
| Spinal Surgical Devices Technologies and Global Markets |
Aug 2010 | £3,065 | 78% |
| Neurostimulation - Advanced Technologies and Global Market 2009 - 2014 |
Sep 2009 | £2,940 | 78% |
| Neuropathic Pain Drug Pipeline Analysis and Market Forecasts to 2015 |
Dec 2009 | £1,265 | 78% |
| Autoimmune Disease Therapeutics | Oct 2011 | £2,845 | 77% |
| Osteoarthritis Pain Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
May 2011 | £1,265 | 77% |
| Back Pain - Pipeline Review H2 2011 |
Oct 2011 | £315 | 77% |
| Valuing Pharmaceutical Innovation Pricing and Reimbursement for Innovative Therapies |
Jul 2008 | £2,425 | 77% |
| Anticonvulsants Market to 2016 Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants Will Limit Commercial Opportunities for Novel Therapies |
Jan 2011 | £2,215 | 76% |
| CNS Therapeutics | May 2008 | £2,500 | 76% |
| The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 Increasing Generic Competition Creates Challenges |
Mar 2010 | £2,215 | 75% |
| Opioids Market to 2017 Steady Uptake of Oxycontin and High Incidence of Diseases Such as Cancer and Arthritis to Drive The Market |
Jun 2011 | £2,215 | 74% |
| Orexo AB – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 74% |
| LMA International N.V. Market Share Analysis |
Sep 2010 | £630 | 73% |
| Vertebral Compression Fracture Devices | Aug 2010 | £2,500 | 73% |
| Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2010 | Mar 2010 | £995 | 73% |
| Evolution in the Pain Therapy Drugs Market Nociceptive and Neuropathic Drug Development |
Jan 2012 | £1,295 | 71% |
| LMA International N.V. Market Share Analysis | Sep 2010 | £630 | 71% |
| Pharmos Corporation – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 71% |
| Future of the Diabetes Care Devices Market to 2015 | Mar 2009 | £2,215 | 69% |
| Analgesics | Oct 2010 | £2,845 | 69% |
